Viewpoint shift designs drug binding proteins from scratch

A molecular model of apixaban-bound ABLE.

Source: © Nicholas F. Polizzi and William F. DeGrado

New method focuses on the groups touching amino acid side chains

US chemists have developed an approach that could simplify the currently extremely difficult process of custom-designing proteins for a specific job. Nick Polizzi and Bill DeGrado from the University of California, San Francisco (UCSF) used thousands of protein structures in the Protein Data Bank (PDB) to define a new structural unit. Rather than worrying about the exact positioning of side-chains of each amino acid residue in a protein, they shift focus to the chemical groups each residue is in contact with. Using their method they designed two different proteins from scratch that recognise the blood thinner drug apixaban.